117 related articles for article (PubMed ID: 38182000)
1. Prognostication of co-morbidity clusters on hospitalisation and mortality in advanced COPD.
James BD; Greening NJ; Tracey N; Haldar P; Woltmann G; Free RC; Steiner MC; Evans RA; Ward TJ
Respir Med; 2024 Feb; 222():107525. PubMed ID: 38182000
[TBL] [Abstract][Full Text] [Related]
2. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
[TBL] [Abstract][Full Text] [Related]
3. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
4. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
[TBL] [Abstract][Full Text] [Related]
5. The HUNT study: Association of comorbidity clusters with long-term survival and incidence of exacerbation in a population-based Norwegian COPD cohort.
Vikjord SAA; Brumpton BM; Mai XM; Romundstad S; Langhammer A; Vanfleteren L
Respirology; 2022 Apr; 27(4):277-285. PubMed ID: 35144315
[TBL] [Abstract][Full Text] [Related]
6. Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis.
Axson EL; Ragutheeswaran K; Sundaram V; Bloom CI; Bottle A; Cowie MR; Quint JK
Respir Res; 2020 Feb; 21(1):54. PubMed ID: 32059680
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities and COPD severity in a clinic-based cohort.
Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
[TBL] [Abstract][Full Text] [Related]
8. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Esterman AJ; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012347. PubMed ID: 30838649
[TBL] [Abstract][Full Text] [Related]
9. Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis.
Rennard SI; Locantore N; Delafont B; Tal-Singer R; Silverman EK; Vestbo J; Miller BE; Bakke P; Celli B; Calverley PM; Coxson H; Crim C; Edwards LD; Lomas DA; MacNee W; Wouters EF; Yates JC; Coca I; Agustí A;
Ann Am Thorac Soc; 2015 Mar; 12(3):303-12. PubMed ID: 25642832
[TBL] [Abstract][Full Text] [Related]
10. Patterns of multi-morbidity and prediction of hospitalisation and all-cause mortality in advanced age.
Teh RO; Menzies OH; Connolly MJ; Doughty RN; Wilkinson TJ; Pillai A; Lumley T; Ryan C; Rolleston A; Broad JB; Kerse N
Age Ageing; 2018 Mar; 47(2):261-268. PubMed ID: 29281041
[TBL] [Abstract][Full Text] [Related]
11. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
12. Self-management interventions for people with chronic obstructive pulmonary disease.
Schrijver J; Lenferink A; Brusse-Keizer M; Zwerink M; van der Valk PD; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD002990. PubMed ID: 35001366
[TBL] [Abstract][Full Text] [Related]
13. Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study.
Tang R; Fraser A; Magnus MC
BMJ Open; 2019 Oct; 9(10):e030318. PubMed ID: 31662371
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial.
Canepa M; Temporelli PL; Rossi A; Rossi A; Gonzini L; Nicolosi GL; Staszewsky L; Marchioli R; Maggioni AP; Tavazzi L;
Cardiology; 2017; 136(2):128-137. PubMed ID: 27618363
[TBL] [Abstract][Full Text] [Related]
15. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.
Divo M; Cote C; de Torres JP; Casanova C; Marin JM; Pinto-Plata V; Zulueta J; Cabrera C; Zagaceta J; Hunninghake G; Celli B;
Am J Respir Crit Care Med; 2012 Jul; 186(2):155-61. PubMed ID: 22561964
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in comorbidities and mortality risk among patients with chronic obstructive pulmonary disease: a study based on NHANES data.
Li N; Li X; Liu M; Wang Y; Wang J
BMC Pulm Med; 2023 Nov; 23(1):481. PubMed ID: 38031050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
